Zions Bancorporation has authorized a new $75 million stock repurchase program, a move analysts see as a bet on its undervalued shares and a commitment to shareholder returns as regional banks navigate a cautious regulatory environment.
Despite a recent 4.7% stock decline, Edwards Lifesciences (NYSE: EW) boasts a robust 13% Return on Equity, outperforming its industry. Yet, its modest 4.6% five-year growth rate raises questions about future potential and market valuation.
Despite a recent stock dip, ASML's record order book, driven by surging demand for advanced memory systems, points to sustained growth as AI and data center expansions create a 'perfect storm' for the lithography giant.
The CrossCurve DeFi protocol has contained a bridge attack exploiting a smart contract flaw, preventing the circulation of stolen tokens. As January's crypto thefts surge to an 11-month high, the team issues a 72-hour ultimatum for the return of funds.
As Bitcoin and Ethereum lead a broad crypto sell-off, three altcoins buck the trend with notable gains. Analysts point to upcoming U.S. economic events as the next major catalyst for market direction.
Investment firm Ashva Capital Management highlights Advanced Micro Devices (AMD) in its latest investor letter, citing the chipmaker's disciplined execution as a cornerstone for enduring growth, even as the fund's overall 2025 returns trailed major indices.
Investment firm Ashva Capital Management reveals Micron Technology as its largest holding in its latest investor letter, detailing a conviction play on the memory chip giant's long-term trajectory amid AI-driven demand and market volatility.
Shares of Canadian challenger bank EQB have delivered stellar long-term gains, significantly outperforming the broader market. While recent momentum has cooled, the stock's journey offers insights into the power of dividends and shifting market sentiment.
With a 25% government bonus and tax-free growth, the Lifetime ISA remains a key tool for first-time buyers and retirement savers. We review the top cash and investment providers for 2026, as the scheme faces a planned 2028 overhaul.
Investment firm Giverny Capital outlines its rationale for adding Watsco to its portfolio, highlighting a value-oriented strategy as markets remain dominated by AI euphoria. The firm's latest investor letter reveals a challenging quarter of narrow returns.
Investors in lighting specialist FW Thorpe have seen a negative total shareholder return of 25% since 2021, starkly underperforming the broader market's gains. Despite steady revenue growth, the share price decline highlights a disconnect with company fundamentals.
A recent anniversary event for 'Silicon Alley' highlighted how New York's technology sector has evolved from a concentrated downtown community into a vast, decentralized force spanning finance, AI, and e-commerce.
Despite a robust 57% return over three years, a deep dive into Warby Parker's financials reveals a significant disconnect between its current share price and intrinsic value estimates, raising questions about its growth trajectory justifying the premium.
Vistra Corp's impressive 23% return on equity stands out in the renewable energy sector, but a deeper look reveals a capital structure heavily reliant on debt, prompting analysts to weigh stellar returns against underlying financial risk.
A combination of moderating inflation and resilient corporate earnings is setting the stage for sustained stability in stock markets, with the recent rally now encompassing small-caps, value stocks, and multiple sectors.
In a significant step toward reconciliation, Syrian interior ministry forces entered the Kurdish-administered city of al-Hassakeh on Monday. The move, part of a fragile new agreement with the Syrian Democratic Forces, aims to cement a ceasefire and outlines a path for the integration of Kurdish-led institutions into the state's security and administrative framework.
Footwear giant Deckers Brands announced a 7.1% rise in Q3 FY26 net sales to $1.95 billion, driven by explosive growth from its HOKA running brand and solid gains from UGG, despite a challenging retail environment.
The pharmaceutical giant's final major U.S. facility will rise in Pennsylvania's historic Lehigh Valley, aiming to produce its promising triple-hormone drug retatrutide and bolster domestic supply chains for blockbuster obesity treatments.
Schweiter Technologies (SWTQ) has seen significant price swings on the SIX Swiss Exchange. With its current valuation trading well above industry peers, we examine whether the stock's optimistic growth prospects justify the premium or if investors should wait for a better entry point.
IQVIA Holdings Inc. (NYSE:IQV) boasts a robust 20% Return on Equity, significantly outpacing its industry. However, a deeper look reveals a heavy reliance on debt, prompting analysts to weigh impressive profitability against underlying financial risk.
